
Xebra Brands Ltd.'s (OTCQB:XBRAF) (CSE:XBRA) (FSE: 9YC) cannabis cultivation in the Netherlands is in the flowering stage, just about ready to harvest and submit samples to Dutch authorities by the end of March. Two samples will be delivered - one with high THC ±22% and one with equal parts THC ±6% and CBD± 8%.
As the only one of five companies selected by the Dutch government to participate in a medicinal cannabis cultivation pilot, Xebra is seeking 1 of 2 licenses with a contract for up to 6 years, which will provide for revenues of up to $80 million to co-supply all pharma-grade cannabis to be sold through pharmacies in the Netherlands